Heart Failure With Preserved Ejection Fraction An Issue Of Heart Failure Clinics E Book

This issue of Heart Failure Clinics, guest edited by Geu-Ru Hong, will cover key topics in Heart Failure with Preserved Ejection Fraction. This issue is one of four selected each year by our series consulting editor, Dr. Eduardo Bossone. Topics discussed in this issue will include: Current Trends and Outcomes of Heart Failure with Preserved Ejection Fraction, Pathogenesis and Phenotypes of Heart Failure with Preserved Ejection Fraction, Hypertension and Heart Failure with Preserved Ejection Fraction, Obesity in Heart Failure with Preserved Ejection Fraction, Noninvasive Hemodynamic Evaluation at rest in Heart Failure with Preserved Ejection Fraction, Clinical Phenogroups in Heart?Failure With Preserved Ejection Fraction and response to therapy, among others.

This issue of Heart Failure Clinics examines Heart Failure with Preserved Ejection Fraction (HFPEF). The followings aspects of HFPEF are addressed: epidemiology, etiologic factors and pathophysiology, diagnosis, clinical spectrum, imaging, invasive hemodynamic characterization, exercise physiology, natriuretic peptides, novel biomarkers, differential diagnoses and comorbidities, outcomes, clinical trials, current therapeutic approach, and novel therapeutic targets.

This issue of Heart Failure Clinics, guest edited by Drs. Giuseppe Pacileo, Daniele Masarone, Francesco Grigioni and Luciano Potena, will cover key topics in Advanced Heart Failure: From Pathophysiology to Clinical Management. This issue is one of four issues selected each year by our series consulting editor, Dr. Eduardo Bossone. Topics discussed in this issue include (but are not limited to): Pathophysiology of advanced heart failure: what I need to know for clinical management?, Advanced heart failure: definition, epidemiology and clinical course, Echocardiography in advanced heart failure: beyond diagnosis, Disease modifier drugs in patients with advanced heart failure: How to optimize their use?, Congestion in patients with advanced heart failure: Assessment and treatment, Inotropes in patients with advanced heart failure: Not only palliative care, Cardiac resynchronization therapy and cardiac contractility modulation in patients with advanced heart failure: How to select the right candidate?, Mitral and tricuspid valves percutaneous repair in patients with advanced heart failure: Panacea, or Pandora's box?, Left ventricular assist device: Indication, timing and management, Listing criteria for heart transplant: Role of cardiopulmonary exercise test and of prognostic scores, Right heart catheterization in patients with advanced heart failure: when to perform, how to interpreter?, Advanced heart failure in special population: Cardiomyopathies, Advanced heart failure in special population: Pediatric age, Advanced heart failure in special population: Heart failure with preserved ejection fraction and Treatment of advanced heart failure: What future holds?. Provides in-depth, clinical reviews on advanced heart failure, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

This issue of Heart Failure Clinics examines the pharmacologic approaches to heart failure: optimizing established therapy with a look toward future agents. Topics include the pathophysiologic foundation for the pharmacologic treatment of heart failure, treatment of heart failure with reducted ejection fraction and preserved ejection fraction, treatment of acute heart failure, investigational treatments, and the role of congestive heart failure medications following left ventricular assist device.

In this issue of Heart Failure Clinics, guest editors Drs. Vijay Rao and Geetha Bhatt bring their considerable expertise to the topic of Novel Non-pharmacological Approaches to Heart Failure. Recent years have seen a multitude of new devices and non-pharmacologic approaches to heart failure (HF), which, in the properly selected patient, can have significant impacts on morbidity and mortality. This issue provides a contemporary summary of these innovative approaches from leaders in the field. Contains 14 relevant, practice-oriented topics including barostimulation in HF; remote monitoring devices in HF; HIS bundle pacing in HF; A.fib ablation and HF (CASTLE-AF) and beyond; interatrial shunt devices; stem cell therapy in HF; novel approaches to sleep apnea in HF; and more. Provides in-depth clinical reviews on novel non-pharmacological approaches to heart failure, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more. Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more. Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This issue of Heart Failure Clinics, guest edited by Gina Price Lundberg and Laxmi S. Mehta, with consulting editor Eduardo Bossone, will focus on Heart Failure in Women. Topics include, but are not limited to, Gender Based Differences in Risk Factors for Development of Heart Failure, Imaging of Heart Failure , Heart Failure with Preserved Ejection Fraction in Women, Heart failure with Reduced Ejection Fraction in Women, Peripartum Cardiomyopathy, Stress Induced Cardiomyopathy, Atrial fibrillation and Heart Failure in Women, Breast Cancer and Heart Failure, Valvular Heart Disease and Heart Failure in Women, Congenital Heart Disease and Heart Failure, Advanced Therapies for Advanced Heart Failure in Women, CRT and ICDs in Women, Heart Transplants and Women, Sleep apnea and Heart Failure in Women, and Pulmonary Hypertension in Women.

Accounting for more than 40% of all heart failure problems, diastolic heart failure is a complex and often difficult diagnosis with rapidly evolving diagnostic management protocols. Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction, 2nd Edition, brings you up to date and equips you to successfully diagnose and manage even the most challenging incidences of diastolic heart failure and their comorbidities. It incorporates the latest guidelines for the diagnostic evaluation of the patient with suspected or known diastolic dysfunction, provides a comprehensive review of clinical conditions associated with heart failure with preserved ejection fraction, and describes the complementary role of imaging modalities and novel therapeutic approaches. Keeps you current with recent extensive changes in the understanding of the mechanisms of diastolic heart failure with preserved ejection fraction (HFpEF) that have resulted in dramatic changes in treatment guidelines. Covers the latest molecular, genetic, and cellular mechanisms behind diastolic heart failure as a basis for the latest clinical approaches, diagnosis, and treatment of common and uncommon pathological conditions such as hypertensive heart disease, cardiomyopathies, arterial and valvular diseases, pericardial diseases, congenital heart disease, diabetes mellitus, and metabolic syndrome. Features 50 video cases, new key summary points, new multiple-choice review questions, and six new chapters: Evaluation of Diastolic Function by Radionuclide Techniques; Diastology Stress Test; ASE/EACVI Diastolic Guidelines; Valve Disease; Perioperative Assessment of Diastolic Dysfunction; and Pulmonary Hypertension. Reviews new techniques and indices for assessing diastolic function, such as 3D echo, strain rate imaging, late gadolinium enhancement and T1-mapping by CMR, and novel nuclear scintigraphic methods – as well as the traditional indices of LV filling, LA function, and tissue Doppler indices. Covers emerging topics such as the role of neurohormones, global and regional systolic function of the left ventricle, chronotopic incompetence and pacing, aging, perioperative assessment, and more. Presents information in a quick-retrieval format, covering Epidemiology, Pathophysiology, Diagnostic Evaluation, Differential Diagnosis, Treatment, and Future Directions. Helps you learn efficiently and prepare for self-assessment with key summaries and multiple-choice questions and answers for each chapter.